VJOncology is delighted to be attending the European Society for Medical Oncology (ESMO) Congress 2026. Our Editorial and Partnerships teams will be onsite in Madrid, and you can meet us at our booth (P8099), where we’ll be showcasing our disease education channels and latest independent medical education (IME) initiatives.
Our Editorial team will be focused on delivering rapid, independent coverage of the most important advances in oncology. From real-time updates to in-depth analysis of practice-changing clinical trials with global thought leaders, we are committed to providing healthcare professionals (HCPs) with high-quality, open-access IME. Stay tuned for the latest news, insights and education in solid tumors across our VJOncology disease education channels.
Our mission to deliver innovative and impactful educational content is made possible thanks to support from our industry partners. For pharmaceutical and biotech companies, supporting VJOncology’s activities offers a unique opportunity to champion HCP education through trusted IME programs. Our platform is recognized by oncology professionals for its integrity and depth, and stands as a credible source for clinical insights. By enabling meaningful scientific dialogue and amplifying key congress data, VJOncology is able to continue reaching a global audience far beyond the meeting itself.
If you would like to be part of this mission to deliver high-quality IME, or to connect with us in person at ESMO, get in touch by emailing supporter@medicalpublishing.co.uk or simply contact us here.
The content from last year’s meeting is hosted on our dedicated ESMO 2025 page on VJOncology.

